# US 2001/0026808 A1 · Anti-inflammatory pharmaceutical formulations

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2001/0026808 A1
- Document ID: US20010026808A1
- Status: Published application
- Kind: A1
- Application number: 09/789,365
- Filed: 2001-02-20
- Published: 2001-10-04
- Earliest claimed: 1998-07-07
- Assignees: Norton Healthcare Limited
- Inventors: Austen John Woolfe; Gordon McIntyre; Nitin Vadilal Sheth
- Web page: https://patentgrep.com/patent/US20010026808A1

## CPC

- A61K 9/2081: {with microcapsules or coated microparticles according to A61K9/50}
- A61K 31/557: Eicosanoids, e.g. leukotrienes {or prostaglandins}
- A61K 9/209: {containing drug in at least two layers or in the core and in at least one outer layer}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

A pharmaceutical dosage form comprising a tablet containing a non-steroidal anti inflammatory drug and misoprostol, wherein the non-steroidal anti inflammatory drug is in the form of coated pellets.

## Claims

### Claim 1

A pharmaceutical dosage form comprising a tablet containing a non-steroidal anti inflammatory drug and misoprostol, wherein the non-steroidal anti inflammatory drug is in the form of coated pellets.

### Claim 2 (depends on 1)

A dosage form as claimed in claim 1 containing a uniform mixture of coated non-steroidal anti inflammatory pellets and misoprostol.

### Claim 3 (depends on 1)

A dosage form as claimed in claim 1 comprising a bilayer tablet containing coated non-steroidal anti inflammatory pellets in one layer and misoprostol in a second layer.

### Claim 4 (depends on 1)

A dosage form as claimed in claim 1 wherein the pellets include an overcoating of a barrier layer upon a pellet including a layer of non-steroidal anti inflammatory drugs sprayed or otherwise coated on a non-pariel core.

### Claim 5 (depends on 1)

A dosage form as claimed in claim 1 wherein the coating is an enteric coating.

### Claim 6 (depends on 5)

A dosage form as claimed in claim 5 wherein the enteric coating is selected from: a methylmethacrylate copolymer, a polyvinylacetate phthalate, cellulose acetate phthalate, or hydroxypropylmethyl cellulose phthalate.

### Claim 7 (depends on 6)

A dosage form as claimed in claim 6 wherein the enteric coat includes a plasticiser.

### Claim 8 (depends on 5)

A dosage form as claimed in claim 5 including a barrier inert coat disposed between the drug core and the enteric coating.

### Claim 9 (depends on 7)

A dosage form as claimed in claim 7 wherein the barrier coat is a cellulose derivative.

### Claim 10 (depends on 1)

A dosage form as claimed in claim 1 wherein the pellets are coated with a barrier coat adapted to delay release of the non-asteroidal anti inflammatory drug.

### Claim 11 (depends on 1)

A dosage form as claimed in claim 1 wherein the pellets are coated with a delay release coat adapted to release the drug throughout the gastrointestinal tract.

### Claim 12 (depends on 11)

A dosage form as claimed in claim 11 wherein the delay release coat is formed from a methacrylate polymer or a mixture of a methacrylate polymer and a cellulose derivative.

### Claim 13 (depends on 1)

A dosage form as claimed in claim 1 wherein the pellets have a diameter of 0.25 to 1.5 mm.

### Claim 14 (depends on 13)

A dosage form as claimed in claim 13 wherein the pellets have a diameter of 0.8 to 1.2 mm.

### Claim 15 (depends on 1)

A dosage form as claimed in claim 1 including one or more excipients selected from binders, lubricants, colorants, bulking agents and disintegrants.

### Claim 16 (depends on 1)

A dosage form as claimed in claim 1 wherein the non-steroidal anti inflammatory drug is diclofenac.

### Claim 17 (depends on 1)

A dosage form as claimed in claim 1 wherein the non-steroidal anti inflammatory drug is ketoprofen.

### Claim 18 (depends on 1)

A dosage form as claimed in claim 1 wherein the non-steroidal anti inflammatory drug is naproxen.

### Claim 19 (depends on 1)

A dosage form as claimed in claim 1 wherein the non-steroidal anti inflammatory drug is selected from piroxicam and meloxicam.

### Claim 20 (depends on 1)

A dosage form as claimed in claim 1 comprising a tablet overcoated with a sugar or cellulose film barrier coating.

### Claim 21 (depends on 1)

A dosage form as claimed in claim 1 comprising a tablet overcoated with a barrier or taste masking coating.

### Claim 22 (depends on 1)

A dosage form as claimed in claim 1 comprising a tablet wherein the ratio of diclofenac to excipients either in the whole tablet or in the diclofenac layer is between 70:30 and 30:70 parts by weight.

### Claim 23 (depends on 1)

A method of manufacture of a pharmaceutical dosage form as claimed in claim 1 wherein the pellets are formed by extrusion and spheronisation of a mixture containing a non-steroidal anti inflammatory drug, followed by coating with a barrier coat.

### Claim 24 (depends on 1)

A method of manufacture of a dosage form as claimed in claim 1 wherein the pellets are made by coasservation or precipitation from solution.

### Claim 25 (depends on 24)

A method as claimed in claim 24 wherein an enteric coat is formed by contacting solutions of an alkali salt of a non-steroidal anti inflammatory drug, and enteric form forming polymer and an acid.

### Claim 26 (depends on 24)

A method as claimed in claim 24 wherein the misoprostol is absorbed onto hydroxypropylmethylcellulose or other cellulose derivative prior to incorporation into a tablet.

### Claim 27

A method of manufacture of a pharmaceutical tablet comprising the steps of mixing a coated pellet containing a non-steroidal anti inflammatory drug together with a powder containing misoprostol absorbed on a cellulose, polyvinylchloride or other excipient optionally together with one or more binding agents, bulking agents, disintegrants and lubricants and compressing the mixture to form tablets.

### Claim 28

A method of manufacture of a pharmaceutical bilayer tablet consisting of mixing coated pellets containing a non-steroidal anti inflammatory drug with optional excipients selected from binders, bulking agents, disintegrants and lubricants; compressing the mixture to form the bottom half of a tablet and superimposing a mixture of misoprostol absorbed on a cellulose or polyvinylchloride or other material together with or more optional excipients selected from binders, bulking agents, disintegrants and lubricants; to form a tablet suitable for human administration.
